Amit Chowdhry, MD, PhD
@amit_chowdhry
Followers
674
Following
2K
Media
1
Statuses
479
Assistant Professor @WilmotCancer @statsROC, GI Radiation Oncologist and Biostatistician. Clinical Trials, Causal Inference, Machine Learning/AI, Meta-Analysis.
Joined June 2009
Our review on Multiplicity in Clinical Trials is now out in the Red Journal, with @NRGonc Stephanie Pugh, John Park @VAKansasCity, @DrJohnKang @KuganSvoid. #radonc #stats.
3
9
32
RT @ASTRO_org: New in the @washingtonpost: A patient’s eye view of radiation therapy: This is what it feels like .Kudos to the team of prof….
0
4
0
RT @GaryMarcus: It’s not just the Apple paper. Reasoning outside the distribution has been the core problem for neural networks for 30 yea….
0
53
0
RT @DrSpratticus: This will grab headlines but they used the ChatGPT 4 model which is for basic reasoning, which I would not consider tumor….
0
11
0
RT @nlinmd: What happens when you query chatGPT with 362 breast cancer cases?. -46% responses differed from breast cancer expert opinion. -….
0
36
0
RT @NiuSanford: 🚨Study activated!. NRG GI-011: Ph 3 RCT of Dose-Escalated RT in Locally Advanced Pancreas Cancer (LAP100). Here's a short (….
0
42
0
RT @KrishanJethwa: 🚨SPRING-01🚨. 🔍Locally Advanced Rectal Cancer. RCT: .25 Gy x 5 ➡️ CAPOX +- Sintilimab. 🔥+ Sintilimab demonstrated:. ✅⬆️pC….
0
33
0
RT @KrishanJethwa: 🙌CHECKMATE 8HW, long term outcomes🙌. 🔍dMMR mCRC. ✅Ipi+ Nivo continues to demonstrate substantially improved PFS compared….
0
20
0
RT @jryckman3: 🧵1/. Big news in unresectable stage III NSCLC. The InTRist study is the first randomized trial comparing NAC vs. neoadjuvan….
0
37
0
RT @KrishanJethwa: 🔥❓Is Pre-op Chemoradiation the new SoC for locally advanced gallbladder cancer❓🔥. 🚨POLCA-GB🚨.T3-4 or N+ GB cancer.🔍Gem-C….
0
76
0
RT @KrishanJethwa: 🚨CM-577, long term🚨. Resected E/GEJ cancer s/p neoadjuvant CRT + surgery; path residual disease:. 🔍Randomized: .12 m niv….
0
29
0
RT @5_utr: ‼️ TAUTEM. Phase 3 RCT T2-3bN0M0 rectal cancer -> chemoradiation and transanal excision vs TME. DFS in both groups was 88.9%!. W….
0
32
0
0
14
0
RT @AdamMGrant: The most underrated career skill is the ability to receive tough love. Acquiring knowledge is easy. Obtaining constructive….
0
702
0
RT @TonyFelefly: @KrishanJethwa @SuyogCancer Exactly! This is the classical large p-value misinterpretation @5_utr.
0
1
0
RT @KrishanJethwa: @SuyogCancer OS not statistically significant per p<0.05 definition but that’s clinical very significant. Interestingly,….
0
3
0
RT @NiuSanford: Wow, this trial showed no OS benefit to FOLFIRINOX vs. single agent gemcitabine in locally advanced pancreas cancer (differ….
0
53
0
RT @PavlosMsaouel: Appreciate @signmagazine making the primer on randomized non-comparative trials (RNCTs) freely available help to raise a….
0
13
0
RT @fumikochino: Deeply saddened that the entire team @NCICancerCtrl @theNCI PDQ Cancer Information has been eliminated. Our evidence-bas….
0
36
0